Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Short-term Investments (2020 - 2021)

Historic Short-term Investments for Black Diamond Therapeutics (BDTX) over the last 2 years, with Q3 2021 value amounting to $188.4 million.

  • Black Diamond Therapeutics' Short-term Investments fell 3195.3% to $188.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $188.4 million, marking a year-over-year decrease of 3195.3%. This contributed to the annual value of $280.5 million for FY2020, which is N/A changed from last year.
  • As of Q3 2021, Black Diamond Therapeutics' Short-term Investments stood at $188.4 million, which was down 3195.3% from $226.1 million recorded in Q2 2021.
  • In the past 5 years, Black Diamond Therapeutics' Short-term Investments ranged from a high of $280.5 million in Q4 2020 and a low of $140.5 million during Q2 2020